Search Results for "Brian Groves Pfizer Bio"

03:27 EDT 4th August 2015 | BioPortfolio

Matching Channels

CTLA4 Mab rDNA Pfizer

Insulin rDNA inhaled Pfizer

Lymphocyte Immune Globulin Pfizer

Somatropin Hgh rDNA Pfizer

What is GENOTROPIN? GENOTROPIN (somatropin [rDNA origin] for injection) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference i...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

GLI names VP of scientific and regulatory affairs

Dr Brian Harvey joins from Pfizer

Remembering Brian Murphy

The MassBio team mourns the death of Brian P. Murphy, Cambridge's assistant city manager for community development. Brian has been a strong partner and advocate for responsible, sustainable growth of ...

Pfizer expands Cambridge Kendall Square research facility

Pfizer has expanded its lease agreement with a subsidiary of Massachusetts Institute of Technology, creating a unified Pfizer campus.With this expansion, Pfizer has leased the full 500,000 square fee...

Pfizer’s Investment Strategy

Pfizer recognises the importance of biotechnology and the need for good science. Barbara Dalton and Daniel Grant explain their different roles in Pfizer and the ways in which the company can invest to...

Pfizer: Um den Schrumpfkurs zu bremsen, setzt Pfizer auch auf Zukäufe!

Volker Gelfarth Lieber Leser, Pfizer, gegründet 1849, gehört nach den Übernahmen von Wyeth und Pharmacia zu den weltweit größten Pharma- konzernen. Mit seinen verschreibungspflichtigen Medikament...

Pfizer Buying Hospira for $15.23B

NEW YORK (AP) — Pfizer is buying Hospira for approximately $15.23 billion, saying it is a good fit with its established global pharmaceutical business.The buyout will also help Pfizer tap into the g...

Pfizer’s Out-licensing Opportunities

In 2008 Pfizer refined their R&D strategy and decided to decrease the number of therapeutic areas that their teams were focusing on. The result of this decision is that the company now has approximate...

Take a look inside Pfizer’s pretty non-Pfizer innovation room

Up on the seventh floor of Pfizer’s cold, black-and-gray exteriored world headquarters in New York is a weird little room with a quirky little poster that will be used (and...

Matching PubMed Articles

Living on the Edges: Spatial Niche Occupation of Asian Citrus Psyllid, Diaphorina citri Kuwayama (Hemiptera: Liviidae), in Citrus Groves.

The spatial niche occupation of the Asian citrus psyllid, Diaphorina citri Kuwayama, 1908, was evaluated to determine its field colonization and food resource exploitation strategies in citrus groves....

Pfizer joins PD-L1 pursuit.

Continuous and Semi-continuous Cell Culture for Production of Blood Clotting Factors.

Recombinant clotting factors are important biotherapeutics that Pfizer has produced and marketed for over fifteen years. Owing to the complexity of the structure and function of these blood factors, i...

In response to Letter to the Editor (Regina Hofmann-Lehmann, Laura S. Levy and Brian Willett)-Comparing the efficacy of FeLV vaccines.

Brazilian Nephrology pays homage to Peter Brian Medawar.

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement